Multiphasic CECT
Cross-source consensus on Multiphasic CECT from 1 sources and 5 claims.
1 sources · 5 claims
Uses
Dosage & preparation
Preparation
Risks & contraindications
Highlighted claims
- The CECT protocol uses intravenous iodinated contrast of at least 300 mgI/mL at 1.5–2.0 mL/kg body weight. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- CT in the AMRICT trial is performed on multidetector scanners with at least 64 detector rows according to LI-RADS recommendations. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- CECT includes late arterial, portal venous, and delayed phase acquisitions. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- Repeated long-term CT surveillance creates a cumulative radiation burden. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol
- Multiphasic CECT is standard practice during the first two years after curative HCC treatment when recurrence risk is highest. — Multicentre prospective trial of abbreviated MRI using gadoxetic acid versus CT for detection of late recurrent HCC (AMRICT): study protocol